Motility assays were performed in
8 μm-pore transwells (Corning Inc. Life Science, Lowell, MA). Cells were cultured to 80% confluence and then starved for 24 h in DMEM containing 1% FBS. 5x10
4 cells (or
HGF siRNA transfected cells) were plated in 200μl of DMEM plus 1% FBS in the upper wells. Bottom wells contained 500μl of DMEM plus 1% FBS with or without
HGF (100 ng/mL) (R&D, Minneapolis, MN). In some cases, both upper and bottom wells received 50 μg/mL
HS20 or human IgG (Sigma St. Louis, MO). Cells were incubated at 37°C in humidified 5% CO2 for 16 h. Cells on the transwells were rinsed in PBS, fixed with 1%
glutaraldehyde (Sigma, St. Louis, MO) in PBS at room temperature for 15 min, and stained with 0.1%
crystal violet (Sigma St. Louis, MO) in water for 30 min. After de-staining in water, non-migrating cells on top of the filter were removed with a cotton swab. Each well was examined and photographed with an AMG EVOS XL microscope. Images were acquired through a phase contrast microscope at 10x magnification. Migrating cells on the bottom of the filter were solubilized in 500 μl of
0.2% Triton X-100 (Invitrogen, Camarillo, CA) at 4°C overnight. The absorbance was measured at 590 nm.
Gao W., Kim H, & Ho M. (2015). Human Monoclonal Antibody Targeting the Heparan Sulfate Chains of Glypican-3 Inhibits HGF-Mediated Migration and Motility of Hepatocellular Carcinoma Cells. PLoS ONE, 10(9), e0137664.